The adipocyte hormone leptin activates signal transducer and activator of transcription 3 (STAT3) in the hypothalamus, mediating increased satiety and increased energy expenditure. To date, leptin-mediated activation of the STAT pathway in vivo has not been established in tissues other than hypothalamus. We now describe leptin receptor expression and in vivo signaling in discrete regions of the mouse gastrointestinal tract. Expression of the functional isoform leptin receptor (OB-Rb) is restricted to the jejunum and is readily detected by RT-PCR in isolated enterocytes from this site. Intravenous injection of leptin rapidly induced nuclear STAT5 DNA binding activity in jejunum of ؉/؉ and obese (ob/ob) mice but had no effect in the diabetic (db/ db) mouse that lacks the OB-Rb isoform. In addition, an induction of the immediate-early gene c-fos is observed in jejunum in vivo. Leptin-mediated induction of a number of immediate-early genes and activation of STAT3 and STAT5 in a human model of small intestine epithelium, CACO-2 cells, corroborate this effect. Furthermore, intravenous leptin administration caused a significant 2-fold reduction in the apolipoprotein AIV transcript levels in jejunum 90 min after a fat load. Our results suggest that the epithelium of jejunum is a direct target of leptin action, and this activity is dependent on the presence of OB-Rb. Lack of leptin or resistance to leptin action in this site may contribute to obesity and its related syndromes by directly affecting lipid handling.
Obesity is the result of an imbalance in energy intake and expenditure. This condition is associated with a number of pathological conditions, including non-insulin-dependent diabetes, cardiovascular disease, hypertension, and insulin resistance, that are characterized typically by inappropriately elevated plasma levels of insulin, glucose, triglycerides, and lipoproteins. Homeostatic mechanisms that coordinate the storage and use of energy from the constituents of a meal are disturbed in this condition, leading to exaggerated adipose tissue deposition. As a result there is a commensurate increase in the synthesis and secretion of the adipose tissue hormone leptin, a recently discovered factor that acts on the hypothalamus to inhibit food intake and increase energy expenditure (1) . The importance of leptin in the regulation of energy balance is accentuated by the profound early onset obesity, hyperinsulinemia, and insulin resistance exhibited by obese (ob/ob) mice, the genetic strain that lacks functional leptin (1) . Upon administration of the recombinant hormone to these mice, they, and to a lesser extent their lean littermates, exhibit a marked reduction in weight and a lowering of plasma insulin and glucose concentrations (2, 3) . A phenotypically similar strain, the diabetic (db/db) mouse, has a defect in the leptin receptor and has been shown to be unresponsive to leptin in a number of in vivo and in vitro experiments (4 -8). Although seemingly rare, examples of leptin deficiency in humans demonstrate that the hormone plays a similar role in humans as it does in rodents (9) . However, the parallel elevation of leptin levels with increased adiposity observed in the majority of rodent obesity models and obese humans implicates a leptin resistance mechanism rather than leptin deficiency as a likely defect contributing to obesity.
The leptin receptor (OB-R) 1 (10) is related to class I cytokine receptors, which include gp130, the common signal transducing component for interleukin 6 and related cytokines that are known to activate latent cytosolic signal transduction and activator of transcription (STAT) proteins (11) . Class I cytokine receptors lack intrinsic tyrosine kinase activity and are activated by ligand-induced receptor homo-or heterodimerization or oligomerization before the activation of receptor-associated kinases of the Janus family. The leptin receptor oligomerizes with itself (12) . Multiple OB-R isoforms exist, of which at least two, OB-Ra and OB-Rb, are generated by alternative splicing (4, 5, 7) . The short isoforms, OB-Ra, OB-Rc, and OB-Rd, contain 34, 32, and 40 amino acid cytosolic carboxyl termini, respectively. One soluble isoform exists, OB-Re, which lacks the transmembrane domain. The OB-Rb isoform contains a fulllength cytosolic domain of 302 amino acids that includes binding motifs required for activation of the Janus kinase (JAK)/ STAT signaling pathway. A point mutation (Gly3 Thr) in the mouse diabetes (db) gene results in a novel splice donor site and a premature translation termination (4, 5) . The truncated OB-R(db) lacks the sequence motifs required for the interaction with JAK and STAT, and evidence from the db/db mouse model suggests that OB-Rb is the sole receptor that can mediate JAK/STAT activation and leptin-mediated effects on food intake and cell proliferation (4, 5, 13) .
It has been demonstrated that leptin can activate the JAK/ STAT and mitogen-activated protein kinase signal transduction pathways in a variety of in vitro systems (7, 14) . To date, leptin signaling in vivo has been restricted to a STAT3-mediated satiety mechanism in the ob/ob mouse hypothalamus (15) . Considerable evidence, however, points to expression of the signaling-competent leptin receptor in peripheral tissues that can mediate functional responses to leptin (8, 16) . Recent work has also shown that leptin administration can reduce circulating triglyceride levels in ϩ/ϩ and ob/ob mice (17) . In the present study, we describe OB-Rb expression in discrete regions of the mouse gastrointestinal tract associated with * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. nutrient absorption and lipid uptake and in a human model of small intestinal epithelium, CACO-2 cells. Administration of leptin rapidly induced nuclear STAT5 DNA binding activity in ϩ/ϩ and ob/ob jejunum but had no effect in the OB-Rb-deficient db/db mouse. Leptin administration results in a 2-fold reduction in apolipoprotein AIV (APO-AIV) transcript levels 90 min after a fat load. Thus, leptin can mediate, through an OB-Rb and a STAT5 mechanism, a negative-feedback signal to a primary site of lipid handling. Lack of leptin or resistance to direct leptin action in this site may contribute to elevated triglyceride and lipoprotein levels observed in obesity and its related syndromes.
EXPERIMENTAL PROCEDURES
Animals and Cells-Six-week-old female wild-type and ob/ob mice of the Aston strain were bred in house and were kept on a 12-h light/12-h dark cycle with ad libitum access to water and laboratory chow (Beekay rat and mouse toxicology diet; Bantin and Kingman, Hull, UK). The in vivo effects of leptin (5 mg/kg) were assessed using recombinant leptin (Peprotech, Rocky Hill, NJ) that was given intravenously via the tail vein. Ten micromolar Tris, which was the diluent, was administered to controls. For studies on the effect of leptin on APO-AIV transcript levels, mice were fasted for 5 h and then given an oral dose (750 l/mouse) of pure vegetable oil (energy per 100 g, 3700 kJ/900 kcal) containing 8% saturates, 61% monounsaturates, and 31% polyunsaturates. Leptin (5 mg/kg, intravenously) was given 15 min before the administration of pure vegetable oil. Mice were killed at intervals by cervical dislocation, and tissues were dissected, cleaned, and washed in ice-cold saline. Tissues were taken fresh for extraction of nuclear proteins as described below or snap-frozen in liquid N 2 and stored at Ϫ80°C. Human CACO-2 Caucasian colon epithelial cells (European Animal Cell Culture, Porton Down, UK) were received at confluency and cultivated in Earles minimal essential medium including 1% nonessential amino acids, 2 mM L-glutamine, 10% fetal calf serum, 100 units/ml penicillin, and 100 g/ml streptomycin (Life Technologies, Inc.) at 37°C in a humidified 5% CO 2 /air cabinet for 3-4 days before experiments. Cells were preincubated for 24 h in serum-free supplemented Earles minimal essential medium with 0.1% BSA. Cells were then incubated in basal Earles minimal essential medium with 0.1% BSA with or without leptin at given concentrations or the Tris control vehicle. Enterocytes from jejunum were isolated, using a slightly modified version of the low-temperature method as described by Flint et al. (18) . Thus jejunum was everted, divided into 2-3-mm lengths, and washed in a ice-cold, oxygenated Hanks' balanced salt solution containing 1.5 mM dithiothreitol and RNase inhibitor (Amersham Pharmacia Biotech). The sections were then suspended in ice-cold calcium chelate buffer (27 mM Na-citrate, 5 mM Na 2 HPO 4 , 96 mM NaCl, 8 mM KH 2 PO 4 , 1.5 mM KCl, 20 mM D-sorbitol, 20 mM sucrose, 2 mM glutamine, 1.5 mM dithiothreitol, and RNase inhibitor) with constant stirring on ice for 20 min. Enterocytes were collected by gentle centrifugation for RNA isolation. This method yields pure villus cells representing fully differentiated enterocytes. Microscopic studies were performed to confirm the purity of isolated villus fractions as described previously (18) .
Leptin Receptor mRNA Expression-Total RNA was isolated from tissues and cells using an RNaid plus kit (BIO 101, La Jolla, CA) and treated immediately with DNase I (Life Technologies). Approximately 4 g of RNA were used to generate cDNA with first-strand cDNA beads (Pharmacia Biotech) and oligo (dT) [12] [13] [14] [15] [16] [17] [18] (Invitrogen, San Diego, CA). The integrity and loading of the RNA was studied by detection scanning of ribosomal rRNA bands (28 and 18 S) in agarose gels. Potential contamination from fat was studied using leptin-specific primers (Table  I) in an RT-PCR amplification. RT-PCR detection of the multiple OB-R transcript isoforms in the mouse gut as well as the OB-Rb transcript in the CACO-2 cells was performed using oligonucleotide primers listed in Table I . All PCR amplifications were performed using AmpliTaq (Perkin-Elmer) at 95°C, 45 s denaturation, 57°C, 45 s annealing, and 72°C, 45 s extension (except that for the long OB-Rb isoform extension, which was for 1 min) in a Progene thermal cycler (Techne, Cambridge, UK). PCR products were then cloned directly into a pCR-TRAP cloning system (GeneHunter Corp., Nashville, TN), and the identity of PCR products was confirmed by sequencing using a ThermoSequenase terminator cycle sequencing kit (Amersham Pharmacia Biotech). For quantitative PCR, cDNA samples from ϩ/ϩ and ob/ob mice were serially diluted, and PCR was performed at a fixed number of cycles (37 for OB-R and 30 for ␤-actin), as described previously (19) .
Immunoblot Analysis of Tissues and Cells-Fresh tissues were homogenized in ice-cold immunoprecipitation assay buffer (1 ϫ PBS, 1% IGEPAL (Sigma-Aldrich Co. Ltd., Dorset, UK), and 0.5% sodium deoxycholate) containing a protease inhibitor mixture (Boehringer Mannheim), and the protein lysates were used for a protein assay (Sigma) and standard Western analysis. Approximately 20 g of protein were mixed with gel loading buffer (4% SDS, 100 mM Tris, pH 6.8, and 100 mM ␤-mercaptoethanol) and resolved on 10% SDS-PAGE. For monolayers of CACO-2 cells, protein was extracted by addition of gel loading buffer to the flasks. Proteins were transferred to polyvinylidene difluoride (Millipore, Bedford, MA) membranes by electrotransfer; immunoblots were performed by blocking in 2% BSA, 10 mM Tris, pH 7.5, 100 mM NaCl, 0.1% and Tween 20; the OB-R was detected with M-18 or N-20 antibodies (Santa Cruz Biothechnology, Santa Cruz, CA); and STAT proteins were detected with STAT5 (C-17; Santa Cruz Biothechnology) and STAT1, -2, -3, and -6 (Transduction Laboratories, Lexington, KY) antibodies. Bands were visualized using an ECL kit according to the manufacturer's instructions (Amersham Pharmacia Biotech).
Nuclear Extracts-CACO-2 cells were immediately placed on ice after treatment, and the medium was removed. Cells were quickly washed with ice-cold PBS and then PBS with 5 mM NaF, 10 mM NaMoO 4 , and 1 mM activated Na 3 VO 4 . Cells were lysed with a hypotonic buffer (400 l/25 cm 2 ) containing 10 mM HEPES, pH 7.9, 10 mM NaMoO 4 , 1 mM Na 3 VO 4 , 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 0.125 M okadaic acid, 1 mM dithiothreitol, 2 g/ml leupeptin, 2 g/ml aprotinin, 50 g/ml AEBSF, and 0.2% IGEPAL CA-630 detergent by cell scraping and gentle trituration. The lysate was incubated on ice for 5 min, and the nuclei were pelleted by microcentrifugation for 20 s at 14,000 rpm. The supernatant was discarded, and the nuclei were gently resuspended in 100 l of high-salt buffer (hypotonic buffer plus 200 mM NaCl and 20% glycerol). Nuclear protein was extracted by rotating the tubes for 30 min at 4°C, and the debris was pelleted by microcentrifugation at 14,000 rpm for 20 min. Nuclear extracts were aliquoted and then snap-frozen in liquid N 2 before gel mobility shift assay (see below). Tissues were dissected, washed in ice-cold saline, minced, and then homogenized in 1:10 (w/v) hypotonic lysis buffer, and nuclear extracts were obtained essentially as described for CACO-2 cells.
Gel Mobility Shift Assays-Five microliters of nuclear extract were used for DNA binding studies with 100 ng/reaction [␥-
32 P]ATP endlabeled probe in DNA binding buffer (10 mM Tris, pH 7.5, 150 mM NaCl, and 1 mM dithiothreitol with 1 g/ml polydeoxyinosine/cytidine (Phar- Expression of the APO-AIV and Immediate-early Gene mRNA Species-Tissues and CACO-2 cells treated for 30 min with or without leptin were immediately snap-frozen in liquid N 2 and RNA extracted as described above. Standard Northern blot hybridization was performed using digoxygenin-labeled cDNA probes to determine c-fos and APO-AIV mRNA levels in vivo. Bound probes were detected by the antidigoxygenin detection system using a polyclonal antibody conjugated to alkaline phosphatase (Boehringer Mannheim) with the chemiluminescent substrate CDP-Star (Tropix, Bedford, MA), and finally bands were quantitated by scanning laser densitometry. Expression of the immediate-early genes c-fos, c-jun, junB, and junD in response to leptin was established by quantitative PCR, using primers listed in Table I .
RESULTS
The multiple OB-R mRNA isoforms were detected, using RT-PCR, in discrete full-thickness segments of the gastrointestinal tract (Fig. 1A) . The different short isoforms, OB-Ra, OBRc, OB-Rd, and OB-Re, are expressed throughout the gut. In contrast, the functional long OB-Rb mRNA is found to be pre- dominantly expressed in jejunum (Fig. 1A) . Using leptin-specific primers, RT-PCR amplification of cDNA samples from jejunum of ϩ/ϩ and ob/ob mice resulted in negative detection, whereas PCR amplification of a common extracellular domain of the OB-R in the same samples was readily obtained (Fig.  1B) . This suggests that the OB-R mRNA expression presented in Fig. 1A is neither a result of contamination from fat tissues nor a result of illegitimate transcription. Enterocytes were isolated from the tunica mucosa of jejunum, and RT-PCR amplification was performed. The functional leptin receptor OB-Rb transcript was readily detected in purified enterocytes isolated from jejunum (Fig. 1B) . Furthermore, expression of the functional leptin receptor OB-Rb mRNA was readily detected in the human model of small intestine epithelium CACO-2 by the use of RT-PCR (Fig. 1B) , confirming the enterocyte as a potential target of leptin action. Western blot analysis of crude protein lysates (20 g) from full-thickness segments of different sections of the mouse gut was performed using antibodies raised against the carboxyl-terminal sequence of the short isoform OB-Ra, a predominant isoform in many tissues (7, 14) . This resulted in a band with a predicted size of ϳ120 kDa, which is predominantly expressed in the small intestine of both ϩ/ϩ and ob/ob mice ( Fig. 2A) . The discrepancy between the results obtained using RT-PCR or Western analysis to detect OB-R expression reflects the difference in the detection limit of these two methods. Accordingly, the Western analysis indicates a difference in the OB-R abundance in different sections of the gastrointestinal tract ( Fig. 2A) . Antibodies raised against the amino-terminal sequence of the common human OB-R receptor detected a ϳ120-kDa protein in the CACO-2 cells, which presumably accounts for the predominant short OB-R isoform (Fig. 2B) .
Relative expression levels of the total OB-R transcript normalized to endogenously expressed ␤-actin were measured in discrete sections of the gastrointestinal tract using primers that recognize a sequence common to all isoforms encoding the amino terminus of the receptor, using the quantitative PCR assay described previously (19) . The ratios of OB-R and ␤-actin PCR products from optimized linear regions of PCR condition, generated from equal volumes of cDNA, were compared (Fig.  3A) . No differences in OB-R mRNA levels were detected between ϩ/ϩ and ob/ob mouse tissues, but the OB-R transcript was 2-3-fold more abundant in small intestine than in stomach and transverse colon (Fig. 3B) . These results agree well with those observed using the Western analysis of OB-Ra distribution ( Fig. 2A) .
To address leptin-signaling mechanisms in the region of the small intestine expressing the OB-Rb, we looked for the presence of the STAT proteins known to transmit the leptin signal. Western blot analysis of ϩ/ϩ and ob/ob jejunum readily detects STAT5 but more weakly detects STAT1 and STAT3 (Fig.   4A ). STAT5 is also well expressed in colon and duodenum (Fig.  4A) . CACO-2 cells also express leptin-responsive STAT isoforms (Fig. 4B) . Overnight fasted ϩ/ϩ and ob/ob mice were FIG. 3 . Relative expression levels of the total OB-R transcript in different sections of the gastrointestinal tract. A, representative gels of PCR amplification of the common OB-R extracellular domain in various sections of the gastrointestinal tract of the ϩ/ϩ mouse, using different amounts of cDNA as described previously (18) . The amount of cDNA in each sample was related to ␤-actin levels and adjusted before dilutions were performed. B, results of a single experiment shown in top panel of A are reproduced in three separate experiments, and the OB-R mRNA levels are normalized to the ␤-actin mRNA from the optimized linear regions of PCR. Similarly, quantitation of OB-R mRNA/␤-actin mRNA is also shown for the ob/ob mouse. Results are expressed as mean Ϯ S.E.
FIG. 2. Western blot analysis of the OB-R receptor in the gastrointestinal tract and CACO-2 cells.
A, OB-Ra detected in different sections of the tract of both ϩ/ϩ and ob/ob mice using an antibody raised against the carboxyl terminus of the short isoform. B, OB-R detected in the human CACO-2 cells using an antibody raised against the amino terminus that is common to all OB-R isoforms. Arrows point at an approximate size of a 120-kDa band. administered 5 mg/kg recombinant murine leptin by tail vein injection. Thirty minutes after injection, mice were killed and the jejunum was removed for preparation of nuclear extracts. We used two selective probes to assess STAT activation by electromobility shift assay analysis. The m67-SIE mutated high-affinity STAT consensus binding element from the c-fos promoter preferentially binds STAT1 and STAT3 but binds STAT5 with low affinity. This probe did not reveal an induction of STAT DNA binding activity in response to leptin treatment in vivo in the mouse gut (data not shown). The rat ␤-casein promoter STAT DNA binding consensus element was used as a selective probe for STAT5 activity in vivo. Leptin treatment induced a marked activation of DNA binding activity in both ϩ/ϩ and ob/ob mice, and this was not observed in control animals treated with Tris only (Fig. 5) . In contrast, the same dose of leptin injected into the db/db mice, which lack the OB-Rb isoform, caused no activation of STAT5 DNA binding in nuclear extracts of jejunum (Fig. 5) . The STAT5 DNA binding activity induced in the ϩ/ϩ and ob/ob jejunum was abolished by a preincubation with specific anti-STAT5a antibody and less markedly with an anti-STAT5b antibody (see results from the ob/ob jejunum in Fig. 5 ). These results suggest that jejunum is a direct target of leptin action, and this activity is mediated through OB-Rb and a STAT5 mechanism.
A 15-min leptin exposure resulted in a dose-dependent activation of STAT DNA binding to the m67-SIE probe in serumdeprived CACO-2 cells. This activity was abolished by an anti-STAT3 antibody, whereas an anti-STAT1 antibody had no effect (Fig. 6 ). In addition, leptin-treated CACO-2 cells exhibited an activation of DNA binding activity of STAT5 to the ␤-casein probe, and supershift studies identified STAT5b as the major factor in the complex (Fig. 6) . Thus, leptin induces nuclear STAT5 DNA binding activity in both mouse jejunum and CACO-2 cells; however, different isoforms of STAT5 seem to form the protein-DNA complex in these two systems.
Leptin administration also produced an induction of the immediate early gene c-fos in the jejunum of ob/ob mice after 30 min (Fig. 7A) . Intravenous injection of 5 mg/kg leptin resulted in a 5-fold increase in c-fos mRNA levels as detected by Northern blot analysis. Similarly, leptin treatment for 30 min caused a dramatic increase in expression of the immediate early genes c-fos, c-jun, junB, and junD in the serum-deprived CACO-2 cells, as determined by quantitative PCR (Fig. 7B) . Because activation of STAT5 is usually not associated with c-fos induction, these results could indicate that other pathways are being activated in addition to the STAT5 pathway in vivo.
We then investigated whether leptin could modulate transcription of genes involved in one of the major functions of jejunum, that is, lipid handling, by measuring the effect of leptin on the APO-AIV mRNA levels. Intravenous injection of 5 mg/kg leptin into ob/ob mice 15 min before the oral administration of a high fat load (pure vegetable oil) resulted in a significant 2-fold reduction in APO-AIV mRNA levels; APO-AIV mRNA/␤-actin mRNA mean Ϯ S.E.: control vehicle, 2.23 Ϯ 0.16; leptin treated, 1.04 Ϯ 0.16 (p Ͻ 0.05; n ϭ 3) 90 min after the high fat load (Fig. 8) . These results suggest that leptin could act as an immediate brake on fat accumulation by reducing transport of dietary triglycerides into plasma.
DISCUSSION
The adipocyte hormone leptin signals to the hypothalamus to inhibit food intake and increase energy expenditure (1) . Leptin has also been reported to play a role in peripheral tissue biology (8, 16, 20, 21 ). Leptin treatment of ϩ/ϩ and ob/ob mice causes a reduction in body weight and fat mass in excess of that resulting from inhibition of food intake only (22) . This would FIG. 5 . Gel mobility shift analysis of STAT DNA binding in mouse jejunum in response to leptin. An induction of STAT5 DNA binding activity to the ␤-casein promoter STAT5 consensus element. Nuclear extracts were prepared and incubated with 32 P end-labeled probe and fractionated on a 4% native PAGE gel. Induction was observed in ϩ/ϩ and ob/ob jejunal nuclear extracts in response to leptin administration (5 mg/kg) after 30 min. Preincubation with anti-STAT5 antibodies reveals that the major complex consists of STAT5a. No induction is observed in nuclear extracts of jejunum from db/db mice or control ϩ/ϩ and ob/ob mice. suggest that leptin can affect fat accumulation, metabolism, and energy homeostasis that is in part independent of the regulation of food intake. We now demonstrate the presence of the full-length leptin receptor OB-Rb in a distinct region of small intestine associated with nutritional absorption and lipid uptake. Also, OB-Rb expression was readily detected in isolated enterocytes and in the intestinal epithelial cell line CACO-2, implicating a role for leptin in enterocyte function. Administration of leptin caused activation of the STAT5 signaling pathway in jejunum after 30 min in ϩ/ϩ and ob/ob mice but not in db/db mice, which lack OB-Rb. Leptin also caused a reduction in the APO-AIV mRNA 90 min after administration of a fat load. The immediate and direct effect of leptin on jejunal lipid handling could represent a front line mechanism against fat accumulation.
The short OB-R isoforms are widely expressed in tissues, whereas the long OB-Rb isoform is more restricted in tissue distribution (7) . OB-Rb is relatively well expressed in hypothalamus, particularly in regions associated with the regulation of body weight homeostasis (23) . However, we and others have identified expression of OB-Rb in peripheral tissues such as pancreatic islets, lymph nodes, and hematopoietic stem cells (7, 8, 21) . Current views hold that only the OB-Rb receptor isoform can activate the JAK/STAT cascade to mediate the biological effects of leptin. This is based on a number of in vivo and in vitro experiments showing that OB-Rb is required to affect food intake and insulin secretion or to stimulate cell proliferation (8, 13, 15) . In these studies the short receptor isoforms, which predominate in most tissues, are unable to mediate such a response to leptin, and no biological function has been assigned to these isoforms to date. It has been suggested that the shorter OB-R isoforms can modify the activity of OB-Rb during homodimerization and subsequent aggregation of the cytosolic domain (7) . This effect of the shorter isoforms seems weak, however, according to the recent data of White et al. (24) who demonstrated that the signaling capacity of OB-Rb is quite resistant to repression by the shorter receptor isoforms. Recently, Lostao et al. (25) located leptin binding sites in the immune cells of the lamina propria of the jejunum, using immunohistochemical experiments. However, these experiments do not discriminate between different OB-R isoforms and thus do not indicate whether the functional OB-Rb isoform is expressed in these cells. More importantly, it is well established that some short OB-R isoforms including OB-Ra are ubiquitously expressed (7, 14) , suggesting that leptin binding sites are common in all tissues. In the present study, we demonstrate that the multiple short isoforms are indeed expressed throughout the gastrointestinal tract, whereas the functional OB-Rb is predominantly expressed in the jejunum and more weakly in ileum, the two major sites that are involved in lipid handling. Furthermore, both Western blot and quantitative PCR analysis show that OB-R is more abundant in the small intestine than in either stomach or colon. In fact, a recent study on the effects of leptin on gastric emptying implied that leptin does not control the delivery rate of the chyme to the small intestine (26) . This is in agreement with the lack of OB-Rb expression found in this site in the current study. The results on OB-R expression suggested to us that small intestine, particularly jejunum, is an important target of leptin action. We also establish expression of the OB-Rb transcript isoform in purified enterocytes from the mouse jejunal epithelium and in the commonly used intestinal epithelial cell model CACO-2, suggesting a role for leptin in the enterocyte function. However, we note that this does not rule out expression of the functional leptin receptor in other layers of the jejunum.
Previous studies in vivo have shown that intravenous injection of leptin induced STAT3 DNA binding activity in ob/ob but not db/db mouse hypothalamus (15) . Nuclear extracts from hypothalamus and several peripheral tissues failed to shift the STAT5-specific ␤-casein promoter element. We show that intravenous injection of leptin induced STAT5 DNA binding activity in jejunum of ϩ/ϩ and ob/ob mice but had no effect in the db/db mouse. Here, we chose a submaximal leptin concentration (5 mg/kg) and an optimal time frame of 30 min based on previous in vivo reports on STAT activation (15) . We do not therefore rule out activation of other leptin signaling mechanisms that do not appreciably overlap this time frame in jejunum. The 5 mg/kg dose is somewhat higher than the reported physiological concentration range of leptin; however, the activity of recombinant leptin from different sources varies significantly. Hence, literature reports show that doses of leptin between 0.1 and 5 mg/kg cause a 50% reduction in food intake. This suggests that some sources of recombinant leptin may be considerably less potent than endogenous leptin.
The rapid activation of STAT5 DNA binding and immediateearly gene transcription is consistent with a direct effect of leptin on the gut. Our in vivo results show that the effect of leptin in jejunum requires the presence of the long OB-Rb isoform. In addition, STAT5 activation and immediate-early gene induction in response to leptin in the human model of small intestinal epithelium, the CACO-2 cell, may be interpreted as corroboration of a direct effect of leptin on enterocytes. That the associated activation of STAT3 and STAT5 in this cell line appears broader than the primary gut tissue is also a recognized phenomenon of in vitro systems (7). The requirement for depriving cells of serum before and during leptin treatment and the use of high concentrations of leptin for the demonstrated activation of the STAT DNA binding in CACO-2 cells has been observed previously in other cell lines (27) . The possible importance of STAT5 in mediating the effect of leptin on body weight homeostasis is further implicated by in vitro evidence from the obese (fa/fa) Zucker rat, which contain a missense mutation (Gln3 Pro) in the extracellular domain of the OB-R (28). OB-R(fa) mediates a leptin-independent (constitutive) activation of STAT1 and STAT3, whereas the activation of STAT5 is completely abolished (29) . These animal models, together with the leptin-deficient (ob/ob) and OB-Rb-deficient (db/db) mice, all develop early onset obesity, and our present data would suggest that a lack of leptin effect through STAT5 in small intestine of these animal models could in part contribute to the obesity phenotype.
The small intestine forms the primary interface between ingested nutrient and the internal environment. During conditions of obesity, endogenous intestinal triglyceride production is increased (30) , contributing to elevated plasma triglyceride levels. Hypertriglyceridemia and hyperlipoproteinemia are risk factors for cardiovascular disease and atherosclerosis (31) . The APO-AIV system serves as a conduit for transport of triglycerides as chylomicrons into the circulation and their transfer to acceptor membranes in various tissues, and furthermore, APO-IV synthesis in the proximal jejunum is stimulated by a fat load (32) . Thus, deregulation of this function could be a part of the mechanism that leads to obesity and elevated levels of lipoproteins. Our results show for the first time that leptin can cause a rapid activation of STAT5 in jejunum, which is associated with a reduction of the APO-AIV transcript levels 90 min after ingestion of a pure fat load. This suggests that leptin might play a physiological role in lipid handling at this site in vivo. In physiological conditions, postprandial rises in plasma leptin (33) could function as a buffer system to reduce the plasma chylomicron triglyceride levels by reducing APO-AIV. It is also possible that leptin may serve as a tonic inhibitory mechanism on the APO-AIV system to reduce the levels of secreted triglycerides. Leptin can induce enzymes of fatty acid oxidation (34) and thus might promote a switch in fuel metabolism to ␤-oxidation of fatty acids, which could account for a reduction in APO-AIV mRNA at the transcriptional and/or FIG. 8 . Leptin administration reduces APO-AIV mRNA levels after a high fat load. Leptin (5 mg/kg, intravenously) treatment results in a significant 2-fold reduction in APO-AIV mRNA levels in jejunum of ob/ob mice. Mice were fasted for 5 h and given leptin intravenously 15 min before oral administration of fat load (750 l of pure vegetable oil). Ninety minutes later mice were killed, and the jejunum was removed for RNA extraction. Expression of APO-AIV mRNA was normalized to 28 S rRNA, and results are expressed as mean Ϯ S.E. (n ϭ 3; ‫,ء‬ p Ͻ 0.05).
posttransciptional level. In the enterocyte, however, the mechanism of leptin-mediated reduction in APO-AIV mRNA levels needs to be defined.
In summary, we have demonstrated a novel peripheral effect of leptin on jejunum function in vivo mediated through the OB-Rb receptor and a STAT5 mechanism. This may represent an adipo-enteric loop providing a negative-feedback signal from fat stores to the intestine to regulate lipid handling.
